Critical Limb Ischemia
📧 Sign up to get email alerts when something new happens for Critical Limb Ischemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2024-09-19Clinical Trial Update: Expanded Access Treatment of Subjects With Critical Limb Ischemia (CLI) With Minor Tissue Loss Who Are Unsuitable for Revascularization
Expanded Access treatment program for Critical Limb Ischemia with minor tissue loss in patients unsuitable for revascularization is no longe…
-
CLINICAL_TRIALS withdrawal · 2017-07-21Clinical Trial Update: Autologous Adipose-Derived Stromal Cell Delivered Via Intramuscular Injections for the Treatment of Critical Limb Ischemia [Phase 1]
A Phase 1 clinical trial evaluating autologous adipose-derived stromal cells delivered by intramuscular injections for critical limb ischemi…
-
CLINICAL_TRIALS withdrawal · 2017-04-13Clinical Trial Update: Correlation Between FlowMet™ and Other Gold Standard Assessments in the Management of Critical Limb Ischemia (CLI) [NA]
The clinical trial investigating FlowMet in the management of critical limb ischemia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-04-07Clinical Trial Update: A Clinical Trial to Study the Efficacy and Safety of Stempeucel® in Patients With CLI Due to Buergers Disease [Phase 2]
The Phase 2 trial evaluating Stempeucel for critical limb ischemia due to Buerger's disease has been withdrawn.